Abstract
ABSTRACT The Brazilian biotechnology health innovation regime can be understood as a phenomenon that results from the co-evolution of scientific, economic, and political factors. In order to analyze this co-evolution process, this article presents empirical evidence regarding the relationship between the public policy rationale devoted to promoting innovation activities and the development of health biotechnology in Brazil. Focusing on the 2002–2010 period, this article analyzes the different roles played by public policy on the development of Brazilian health biotechnology. The article is based on the analysis of two main dimensions: the national research capabilities and the dedicated biotechnology firms in Brazil. In this regard, the main conclusion is that public policies had a significant impact on both dimensions. However, the impact has been erratic and reflects strategic public policy weaknesses.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
